Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon

Creative Commons License

AYTEMİR K., GÜRSES K. M., YALÇIN M. U., KOÇYİĞİT D., Dural M., EVRANOS B., ...Daha Fazla

EUROPACE, cilt.17, sa.3, ss.379-387, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1093/europace/euu273
  • Dergi Adı: EUROPACE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.379-387
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Aims The second-generation cryoballoon (Arctic Front Advance (TM)) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic Front (TM)) (Arc-CB) in patients who underwent pulmonary vein isolation (PVI) for atrial fibrillation (AF).